News and Issues
If You're Looking For A Link To the Mueller Report, Look No Further
Editor's Note:
We're not downloading the entire Mueller report, but here is the Justice Department URL to read the report at:
Report On the Investigation Into Russian Interference In The 2016 Election, Vol I and II; Special Counsel Robert S. Mueller, III
https://www.justice.gov/storage/report.pdf?_ga=2.80421777.744576135.1555603755-461170982.1555603755
Mueller received the following military awards and decorations:
91.0% Efficacy In Preventing Symtomatic Disease: US Clinical Trial Results Show Novavax Vaccine is Safe and Prevents COVID-19
Results from a Phase 3 clinical trial enrolling 29,960 adult volunteers in the United States and Mexico show that the investigational vaccine known as NVX-CoV2373 demonstrated 90.4% efficacy in preventing symptomatic COVID-19 disease. The candidate showed 100% protection against moderate and severe disease. In people at high risk of developing complications from COVID-19 (people 65 years or older and people under age 65 with certain comorbidities or with likely regular exposure to COVID-19), the vaccine showed 91.0% efficacy in preventing symptomatic COVID-19 disease. more »
Prices are Spiking for Homes, Cars and Gas; Don’t Be Alarmed, Economists Say
Republican political leaders are blaming Democratic President Joe Biden for accelerating inflation. But Jerome Powell, chairman of the US Federal Reserve Board, was appointed by Republican President Donald Trump — and the Fed says inflation will not be a long-term problem. Those numbers suggest that inflationary pressures are modest. Other dynamics, however, are unprecedented, reflecting deeper changes in the economy that may have accelerated with the pandemic. But at UC Berkeley, high-level economists are offering some calming advice: A measure of inflation is inevitable as the US economy comes back online, but it will likely be modest. And it will almost certainly blow over as the economy stabilizes. more »
Kaiser Family Foundation: FDA’s Approval of Biogen’s New Alzheimer’s Drug Has Huge Cost Implications for Medicare and Beneficiaries
"The question of what would happen when a new, expensive prescription drug comes to market for a disease like Alzheimer’s that afflicts millions of people has loomed large in discussions over drug prices in the U.S.— and now we’re about to find out. After a nearly 20-year dry spell in new treatments for Alzheimer’s disease, the Food and Drug Administration (FDA) just approved a new Alzheimer’s medication, Aduhelm (aducanumab), developed by Biogen, with an expected annual price tag of $56,000. While the scientific community debates the evidence of the effectiveness of this new drug, the FDA’s decision raises hope for Alzheimer’s patients and their families, along with serious cost concerns for patients and payers, particularly Medicare." more »
Security, Planning, and Response Failures: Senators Peters, Portman, Klobuchar, Blunt Release Bipartisan Report Investigating January 6th Capitol Attack
U.S. Senators Gary Peters (D-MI) and Rob Portman (R-OH), Chairman and Ranking Member of the Homeland Security and Governmental Affairs Committee, and Amy Klobuchar (D-MN) and Roy Blunt (R-MO), Chairwoman and Ranking Member of the Committee on Rules and Administration, released a bipartisan report on the security, planning, and response failures related to the violent and unprecedented attack on January 6th. The report also includes a series of recommendations for the Capitol Police Board, United States Capitol Police (USCP), federal intelligence agencies, the Department of Defense (DOD), and other Capital region law enforcement agencies. more »